| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 293.73B | 296.05B | 313.88B | 307.91B | 243.20B | 214.12B |
| Gross Profit | 31.93B | 31.87B | 30.72B | 22.69B | 22.71B | 21.96B |
| EBITDA | 10.69B | 10.59B | 11.00B | 5.03B | 8.38B | 9.73B |
| Net Income | 5.72B | 5.39B | 5.08B | 1.03B | 3.66B | 4.44B |
Balance Sheet | ||||||
| Total Assets | 126.15B | 124.17B | 131.04B | 127.91B | 108.50B | 99.25B |
| Cash, Cash Equivalents and Short-Term Investments | 9.81B | 10.34B | 10.88B | 7.38B | 3.50B | 2.89B |
| Total Debt | 29.65B | 27.95B | 32.49B | 36.80B | 22.71B | 21.80B |
| Total Liabilities | 69.67B | 68.82B | 80.18B | 82.59B | 63.66B | 56.45B |
| Stockholders Equity | 55.75B | 54.62B | 50.28B | 44.77B | 44.31B | 42.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.91B | 8.49B | -9.89B | 116.00M | 701.00M |
| Operating Cash Flow | 0.00 | 8.57B | 11.14B | -7.82B | 2.74B | 7.74B |
| Investing Cash Flow | 0.00 | -3.27B | -2.17B | -1.19B | -952.00M | -5.99B |
| Financing Cash Flow | 0.00 | -5.83B | -5.47B | 12.88B | -1.17B | -1.55B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥66.70B | 8.46 | ― | 3.63% | 1.78% | 19.50% | |
73 Outperform | ¥44.15B | 5.92 | 11.01% | 3.97% | -5.05% | -16.39% | |
70 Outperform | ¥586.21B | 11.01 | ― | 3.15% | -0.88% | -25.64% | |
69 Neutral | ¥22.69B | 2.45 | ― | 2.54% | 2.80% | 154.89% | |
67 Neutral | ¥67.87B | 20.57 | ― | 3.77% | -3.91% | -25.32% | |
63 Neutral | ¥52.83B | 7.68 | ― | 3.25% | -4.39% | -13.20% | |
57 Neutral | $3.13B | 9.23 | -34.32% | 3.14% | -25.56% | -353.61% |